VirnetX (VHC), which skyrocketed yesterday on the USPTO's denial of Apple's (AAPL) request to...


VirnetX (VHC), which skyrocketed yesterday on the USPTO's denial of Apple's (AAPL) request to reexamine a key patent, is up 2% premarket following positive comments from Cowen. The firm thinks the USPTO's move improves VirnetX's position ahead of a Jan. 5 Markman hearing, and thinks VirnetX's patent claims will largely hold up. It believes shares can double in 2012.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs